Similarly, another study reported that CRC patients with elevated expression of METTL3 showed significantly better survival than those with lower METTL3 expression; up-regulation of METTL3 significantly reduced tumor proliferation, migration and invasion of CRC cells [25, 62]. This evidence concerns the gene METTL3 and neoplasm.